CSPCY
Price
$4.24
Change
+$0.31 (+7.89%)
Updated
Nov 13 closing price
Capitalization
11.68B
Intraday BUY SELL Signals
DSKYF
Price
$21.85
Change
-$0.73 (-3.23%)
Updated
Nov 13 closing price
Capitalization
40.97B
Intraday BUY SELL Signals
Interact to see
Advertisement

CSPCY vs DSKYF

Header iconCSPCY vs DSKYF Comparison
Open Charts CSPCY vs DSKYFBanner chart's image
CSPC Pharmaceuticals Group
Price$4.24
Change+$0.31 (+7.89%)
Volume$9.4K
Capitalization11.68B
Daiichi Sankyo
Price$21.85
Change-$0.73 (-3.23%)
Volume$16.88K
Capitalization40.97B
CSPCY vs DSKYF Comparison Chart in %
CSPCY
Daily Signal:
Gain/Loss:
DSKYF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CSPCY vs. DSKYF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPCY is a Hold and DSKYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CSPCY: $3.93 vs. DSKYF: $22.58)
Brand notoriety: CSPCY and DSKYF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CSPCY: 15% vs. DSKYF: 131%
Market capitalization -- CSPCY: $11.68B vs. DSKYF: $40.97B
CSPCY [@Pharmaceuticals: Major] is valued at $11.68B. DSKYF’s [@Pharmaceuticals: Major] market capitalization is $40.97B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $915.49B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $98.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPCY’s FA Score shows that 2 FA rating(s) are green whileDSKYF’s FA Score has 2 green FA rating(s).

  • CSPCY’s FA Score: 2 green, 3 red.
  • DSKYF’s FA Score: 2 green, 3 red.
According to our system of comparison, both CSPCY and DSKYF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSPCY’s TA Score shows that 4 TA indicator(s) are bullish while DSKYF’s TA Score has 4 bullish TA indicator(s).

  • CSPCY’s TA Score: 4 bullish, 4 bearish.
  • DSKYF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CSPCY is a better buy in the short-term than DSKYF.

Price Growth

CSPCY (@Pharmaceuticals: Major) experienced а +3.83% price change this week, while DSKYF (@Pharmaceuticals: Major) price change was +1.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.48%. For the same industry, the average monthly price growth was +1.46%, and the average quarterly price growth was +19.41%.

Industries' Descriptions

@Pharmaceuticals: Major (+3.48% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSKYF($41B) has a higher market cap than CSPCY($11.7B). DSKYF (22.51) and CSPCY (22.41) have similar P/E ratio . CSPCY YTD gains are higher at: 71.665 vs. DSKYF (-15.117). DSKYF has higher annual earnings (EBITDA): 405B vs. CSPCY (4.94B). DSKYF has higher revenues than CSPCY: DSKYF (1.76T) vs CSPCY (26B).
CSPCYDSKYFCSPCY / DSKYF
Capitalization11.7B41B29%
EBITDA4.94B405B1%
Gain YTD71.665-15.117-474%
P/E Ratio22.4122.51100%
Revenue26B1.76T1%
Total CashN/A848B-
Total DebtN/A102B-
FUNDAMENTALS RATINGS
CSPCY vs DSKYF: Fundamental Ratings
CSPCY
DSKYF
OUTLOOK RATING
1..100
6264
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
803
PRICE GROWTH RATING
1..100
5864
P/E GROWTH RATING
1..100
785
SEASONALITY SCORE
1..100
1450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSPCY's Valuation (14) in the null industry is in the same range as DSKYF (33). This means that CSPCY’s stock grew similarly to DSKYF’s over the last 12 months.

CSPCY's Profit vs Risk Rating (100) in the null industry is in the same range as DSKYF (100). This means that CSPCY’s stock grew similarly to DSKYF’s over the last 12 months.

DSKYF's SMR Rating (3) in the null industry is significantly better than the same rating for CSPCY (80). This means that DSKYF’s stock grew significantly faster than CSPCY’s over the last 12 months.

CSPCY's Price Growth Rating (58) in the null industry is in the same range as DSKYF (64). This means that CSPCY’s stock grew similarly to DSKYF’s over the last 12 months.

CSPCY's P/E Growth Rating (7) in the null industry is significantly better than the same rating for DSKYF (85). This means that CSPCY’s stock grew significantly faster than DSKYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSPCYDSKYF
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 8 days ago
69%
Bullish Trend 17 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 9 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
CSPCY
Daily Signal:
Gain/Loss:
DSKYF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETY15.780.04
+0.25%
Eaton Vance Tax-Managed Diversified Equity Income Fund
TXSS28.17N/A
N/A
Texas Capital Texas Sm Cp Eq Idx ETF
LDRC25.29N/A
-0.02%
iShares iBonds 1-5 Year Corporate Ladder ETF
IBIE26.21-0.02
-0.06%
iShares iBonds Oct 2028 Term Tips ETF
MINO45.65-0.08
-0.17%
PIMCO Muncpl Income Oppos Act Ex-Trd

CSPCY and

Correlation & Price change

A.I.dvisor tells us that CSPCY and CHJTF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSPCY and CHJTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPCY
1D Price
Change %
CSPCY100%
-0.13%
CHJTF - CSPCY
23%
Poorly correlated
-0.00%
DSNKY - CSPCY
16%
Poorly correlated
+1.76%
BAYZF - CSPCY
12%
Poorly correlated
+5.61%
DSKYF - CSPCY
5%
Poorly correlated
+1.94%
CMOPF - CSPCY
4%
Poorly correlated
N/A
More

DSKYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSKYF has been loosely correlated with DSNKY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DSKYF jumps, then DSNKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSKYF
1D Price
Change %
DSKYF100%
+1.94%
DSNKY - DSKYF
34%
Loosely correlated
+1.76%
CHGCY - DSKYF
23%
Poorly correlated
+4.13%
CHGCF - DSKYF
13%
Poorly correlated
+8.56%
CHJTF - DSKYF
7%
Poorly correlated
-0.00%
CSPCY - DSKYF
5%
Poorly correlated
-0.13%
More